Real Locations in Philadelphia, PA and Nationwide
Breast Cancer carrier 96% survival rate
 breast cancer early detection test
A mammogram’s ability to detect cancer accurately is dependent on which radiologist reads it, leading to highly subjective results, according to a Group Health study published in the Journal of the National Cancer Institute
  • No Insurance Needed
  • physician order provided
  • No appointment necessary
  • Confidential and Anonymous
ANY LAB TEST NOW® in Philadelphia, PA 

1 in 8 women are at risk of having breast cancer in their lifetime.

According to the American Cancer Society and National Cancer Institute, the early detection of breast cancer improves the chances that breast cancer can be diagnosed at an early stage and treated successfully.
  • 1 in 8 women are at risk of having breast cancer in their lifetime.
  • More than 211,000 cases of breast cancer are diagnosed annually in the U.S. alone, and over 40,000 women will die of this devastating disease.
  • 45% of women fail to get annual mammograms due to fear, lack of education, socio-economics and/or a false belief that no family history of breast cancer means there is no need to worry.
  • 85% of all breast cancer patients did NOT have a family history of the disease.
  • Mammograms have become a standard component of an annual physical for women over 40, and remain the diagnostic test of choice for breast cancer detection.
  • Mammography is a subjective imaging technique with a 74-78% accuracy rate on average; i.e. 20%-30% of cancers go undetected and 12-15% will be reported as false positives
  • For women under 50 years of age and with denser breast tissue, accuracy of mammography drops significantly with the rate of undetected cancers rising to between 30-40%.
However, the #1 statistic surrounding breast cancer is also true ---
With early detection the 5-year survival rate for breast cancer is near 97%.
When it comes to early detection, the American Cancer Society has stated: Early detection means using an approach that allows earlier diagnosis of breast cancer than otherwise might have occurred. The goal of screening exams for early breast cancer detection is to find cancers before they start to cause symptoms.  Most doctors feel that early detection tests for breast cancer save many thousands of lives each year, and that many more lives could be saved if even more women and their health care providers took advantage of these tests.

What is the BT Test? We recommend all women over the age of 40 get the BT test every year along with their annual screening mammogram. The two together are a more powerful combination for the early detection of breast cancer than either test alone.
Who should get the BT Test? We recommend all women over the age of 40 get the BT test every year along with their annual screening mammogram. The two together are a more powerful combination for the early detection of breast cancer than either test alone.  
Why should I take it? We recommend all women over the age of 40 get the BT test every year along with their annual screening mammogram. The two together are a more powerful combination for the early detection of breast cancer than either test alone.
How does the BT Test work? The BT Test ™ is a non-invasive blood test that has clinically demonstrated greater than 80% accuracy for the detection for breast cancer. The BT Test has been specifically designed to be used by your physician in conjunction with mammography as another tool to assist them in accomplishing the task of early breast cancer detection. The BT Test is a proprietary, patented test procedure that analyzes and evaluates a select combination of known cancer-associated protein biomarkers in blood serum resulting in a first-of-its-kind blood test that can help in early breast cancer detection. *

The BT Test measures a select grouping of well known cancer related proteins in a blood serum sample, and by using a proprietary algorithm to combine that data with a patient’s personal medical profile, a BT Score is generated that reflects the level of probability that breast cancer is present or not.
If I have an abnormal score, does it mean I have breast cancer? An abnormal score is an indicator of an increased likelihood of having breast cancer. The actual diagnosis of cancer can only be confirmed by a tissue biopsy with the specimen examined under a microscope for tumor cells.
Is this like a genetic test? No. Genetic tests establish a risk estimate as to the possibility that the patient may or may not get breast cancer in the future. The BT Test on the other hand, looks at the existing levels of certain cancer associated proteins in the patient’s blood sample and evaluates whether or not the disease is currently present or not based on our clinical trial study results.

Benefits
* Non-invasive, convenient & easy to administer

* Objective analytical technique with known accuracy

* Not subject to physical and/or equipment limitations associated with mammography
 
* Useful in all age groups & even better in women below 50 years of age and dense breast

* Goes beyond density to actual evidence of pathology indication

* Offers the latest advances in Women's Breast Health

Terms of Use | Privacy Statement
For a complete listing of all ANY LAB TEST NOW® locations, please visit www.AnyLabTestNow.com